Quarterly ResultMay 6, 2026, 04:47 PM
BillionToOne Q1 Revenue $108.39M, Swings to Net Income of $17.97M
AI Summary
BillionToOne, Inc. reported strong financial results for the first quarter of 2026, with revenue increasing by 83.8% year-over-year to $108.39 million. The company swung to a net income of $17.97 million, a significant improvement from a net loss of $3.99 million in the prior-year period. This performance was driven by substantial growth in both prenatal and oncology testing services, alongside an amendment to its partnership agreement with Johnson & Johnson.
Key Highlights
- Revenue for Q1 2026 increased 83.8% to $108.39 million from $58.96 million in Q1 2025.
- Net income for Q1 2026 was $17.97 million, compared to a net loss of $3.99 million in Q1 2025.
- Basic earnings per share for Q1 2026 was $0.39, up from a loss of $0.39 in Q1 2025.
- Gross profit for Q1 2026 rose 108.3% to $79.10 million from $37.97 million in Q1 2025.
- Cash and cash equivalents totaled $537.45 million as of March 31, 2026.
- Long-term debt increased to $90.01 million as of March 31, 2026, including $30 million from new debt issuance.
- Prenatal revenue grew to $96.53 million in Q1 2026 from $56.08 million in Q1 2025.
- Oncology revenue increased to $10.72 million in Q1 2026 from $2.18 million in Q1 2025.
Price Impact
More from BLLN